AUROLAB logo

Auro Laboratories Ltd

AUROLAB·BSE·
260.40 +5.35 (+2.10%)
Market Cap151.48 Cr
PE Ratio88.27
Volume13,335
Day High - Low263.80 - 252.15
52W High-Low317.00 - 189.40
DocStoX Score
2.7/10
Poor
Fair Value
Sign in to see
ROE
8.49%
Average
P/E
88.27x
Expensive
Debt / Equity
1.37
Elevated
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day252.15
263.80
52W189.40
317.00
DocStoX take

Held back by valuation (0.0).

DocStoX score

Low confidence
2.7
/10
Poor
Quality
Solid
ROE 8.5%
Valuation
Expensive
P/E 88.3×
Growth
Flat
Revenue -9.6% 5Y CAGR
Risk
Elevated
D/E 1.37
Momentum
Firm
56% of 52-week range

At a glance

Market Cap
₹151 Cr
52W High / Low
₹317 / ₹189
Dividend Yield
0.00%
Promoter Holding
52.40%
EPS (TTM)
₹2.95
Book Value
₹74.36

Key highlights

  • Profitable in all of the last 5 years
  • Profit shrinking 13% a year
  • Revenue shrinking 10% a year
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Auro Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Auro Laboratories Ltd (AUROLAB) Share Price at ₹260.4 (+2.10%) | DocStoX